[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-1-en-105":3,"doc-seo-568780-105":53,"doc-detail-568780-en":126},{"code":4,"msg":5,"data":6},0,"success",[7,14,19,24,29,34,39,44,49],{"id":8,"doc_module":9,"doc_module_name":10,"category_name":11,"show_sort_weight":12,"slug":13},11,1,"Template","Presentations",90,"presentations",{"id":15,"doc_module":9,"doc_module_name":10,"category_name":16,"show_sort_weight":17,"slug":18},12,"Resumes",80,"resumes",{"id":20,"doc_module":9,"doc_module_name":10,"category_name":21,"show_sort_weight":22,"slug":23},14,"Invoices",70,"invoices",{"id":25,"doc_module":9,"doc_module_name":10,"category_name":26,"show_sort_weight":27,"slug":28},15,"Posters",60,"posters",{"id":30,"doc_module":9,"doc_module_name":10,"category_name":31,"show_sort_weight":32,"slug":33},16,"Social Media",50,"social-media",{"id":35,"doc_module":9,"doc_module_name":10,"category_name":36,"show_sort_weight":37,"slug":38},17,"Forms",40,"forms",{"id":40,"doc_module":9,"doc_module_name":10,"category_name":41,"show_sort_weight":42,"slug":43},18,"Letters",30,"letters",{"id":45,"doc_module":9,"doc_module_name":10,"category_name":46,"show_sort_weight":47,"slug":48},21,"Paper Templates",5,"papers-templates",{"id":50,"doc_module":9,"doc_module_name":10,"category_name":51,"show_sort_weight":4,"slug":52},158,"General","general-158",{"code":4,"msg":54,"data":55},"ok",{"site_id":56,"language":57,"slug":58,"title":59,"keywords":60,"description":61,"schema_data":62,"social_meta":119,"head_meta":121,"extra_data":123,"updated_unix":125},105,"en","gloss-tirzepatide-weekly-injection-schedule","Gloss - Tirzepatide Weekly Injection Schedule","","This document provides a comprehensive weekly injection schedule for Tirzepatide combined with Niacinamide, specifically formulated at a concentration of 8/2 mg/mL. The guideline outlines a structured four-phase dosage protocol spanning fourteen weeks, designed to monitor patient tolerance and adjust medication levels effectively. Key instructions emphasize starting at a 2.5 mg dose for initial assessment, with incremental increases to 5 mg, 7.5 mg, and 10 mg based on the absence of sensitivity or adverse side effects.",{"@graph":63,"@context":118},[64,80,101],{"@type":65,"itemListElement":66},"BreadcrumbList",[67,71,74,77],{"item":68,"name":69,"@type":70,"position":9},"https://docshare.wps.com","Home","ListItem",{"item":72,"name":10,"@type":70,"position":73},"https://docshare.wps.com/template/",2,{"item":75,"name":36,"@type":70,"position":76},"https://docshare.wps.com/template/forms/",3,{"item":78,"name":59,"@type":70,"position":79},"https://docshare.wps.com/template/gloss-tirzepatide-weekly-injection-schedule/568780/",4,{"url":78,"name":59,"@type":81,"image":82,"author":87,"headline":59,"publisher":90,"fileFormat":93,"inLanguage":57,"description":61,"dateModified":94,"datePublished":95,"encodingFormat":93,"isAccessibleForFree":96,"interactionStatistic":97},"DigitalDocument",{"url":83,"@type":84,"width":85,"height":86},"https://docshare.wps.com/thumbnails/gloss-tirzepatide-weekly-injection-schedule/568780.png","ImageObject",442,249,{"name":88,"@type":89},"Jacob","Person",{"url":68,"name":91,"@type":92},"DocShare","Organization","application/pdf","2026-10-16","2026-10-13",true,{"@type":98,"interactionType":99,"userInteractionCount":9},"InteractionCounter",{"@type":100},"ViewAction",{"@type":102,"mainEntity":103},"FAQPage",[104,110,114],{"name":105,"@type":106,"acceptedAnswer":107},"What is the starting dose for the Tirzepatide/Niacinamide injection?","Question",{"text":108,"@type":109},"The starting dose is 2.5 mg, which corresponds to 31 units, administered during the first two weeks to assess patient tolerance.","Answer",{"name":111,"@type":106,"acceptedAnswer":112},"When should the dosage be increased according to the schedule?",{"text":113,"@type":109},"The dosage increases occur incrementally every few weeks, moving from 2.5 mg to 5 mg in week 3, 7.5 mg in week 7, and 10 mg in week 11, provided there are no side effects or sensitivities.",{"name":115,"@type":106,"acceptedAnswer":116},"What is the instruction if a patient experiences medication sensitivity?",{"text":117,"@type":109},"If a patient experiences medication sensitivity or side effects, the dosage should not be increased.","https://schema.org",{"og:url":78,"og:type":120,"og:title":59,"og:site_name":91,"og:description":61},"article",{"robots":122,"canonical":78},"index,follow",{"doc_id":124,"site_id":56},568780,1792113280,{"code":4,"msg":5,"data":127},{"doc_id":124,"user_id":128,"nickname":88,"user_avatar":129,"doc_module":9,"category_id":35,"category_name":36,"doc_title":59,"doc_description":61,"doc_content":130,"file_id":131,"file_url":132,"file_type":133,"file_size":134,"view_count":9,"is_deleted":4,"is_public":9,"is_downloadable":9,"audit_status":9,"page_count":9,"language":135,"language_code":57,"site_id":56,"html_lang":57,"table_of_contents":136,"faqs":137,"seo_title":138,"seo_description":61,"update_tm":139,"read_time":4},962084931830,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Tirzepatide/Niacinamide Weekly Injection Schedule  \n8/2 mg/mL CONCENTRATION  \nTirzepatide Strength = 8 mg/mL | 1 mg = 12.5 units  \n\n| Week(s) | Dose (mg) | Units (U) | Notes |\n| --- | --- | --- | --- |\n| Weeks 1–2\u003Cbr>(2 Weeks) | 2.5 mg | 31 units | Start dose to assess tolerance. |\n| Weeks 3–6\u003Cbr>(4 Weeks) | 5 mg | 62 units | Increase if no sensitivity or side effects. |\n| Weeks 7–10\u003Cbr>(4 Weeks) | 7.5 mg | 94 units | Increase only if needed. Do not increase if experiencing medication sensitivity or side effects. |\n| Weeks 11–14\u003Cbr>(4 Weeks) | 10 mg | 125 units | Use only if clinically indicated and welltolerated. Do not increase if experiencing medication sensitivity or side effects. |","cbCaiaK2jW70EMIO","https://ap.wps.com/l/cbCaiaK2jW70EMIO","pdf",133842,"English","# Tirzepatide/Niacinamide Weekly Injection Schedule\n## Dosage and Unit Guidelines\n## Injection Schedule Phases","[{\"question\":\"What is the starting dose for the Tirzepatide/Niacinamide injection?\",\"answer\":\"The starting dose is 2.5 mg, which corresponds to 31 units, administered during the first two weeks to assess patient tolerance.\"},{\"question\":\"When should the dosage be increased according to the schedule?\",\"answer\":\"The dosage increases occur incrementally every few weeks, moving from 2.5 mg to 5 mg in week 3, 7.5 mg in week 7, and 10 mg in week 11, provided there are no side effects or sensitivities.\"},{\"question\":\"What is the instruction if a patient experiences medication sensitivity?\",\"answer\":\"If a patient experiences medication sensitivity or side effects, the dosage should not be increased.\"}]","Gloss - Tirzepatide Weekly Injection Schedule | PDF",1791872364]